Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
AMD$508.30+17.47(+3.75%)What Advanced Micro Devices (AMD) Said on Its Q3 Earnings Call9:15:33 PM ETAMZN$248.54+2.83(+1.15%)Filing: Amazon's previously announced layoffs include 95 jobs in Washington state9:11:34 PM ETAMD$508.30+17.47(+3.75%)AMD's OpenAI, Meta chip deals trigger $1 billion quarterly charge9:10:35 PM ETNKE$38.29-0.83(-2.12%)Nike vs. Procter & Gamble: Which Consumer Stock Is a Better Buy for 2027?9:00:01 PM ETNVS$159.26-2.26(-1.40%)Novartis: 3 Key Takeaways for Long-Term Investors8:27:03 PM ETGOOG$276.96-1.04(-0.37%)Should You Buy Alphabet Stock After Anthropic Raised Its Google Commitment to $121 Billion?8:23:01 PM ETAMD$508.30+17.47(+3.75%)AMD EPS: Intel's Drag Makes No Sense8:16:00 PM ETAMD$508.30+17.47(+3.75%)Advanced Micro Devices, Inc. (AMD) Q3 2026 Earnings Call Transcript8:15:53 PM ETAMGN$456.00-4.12(-0.89%)What Amgen (AMGN) Said on Its Q3 Earnings Call8:15:41 PM ETMPLX$57.70-1.22(-2.07%)Dividend Announcements: October 24-30, 2026 (Part 1 Of 2)8:03:58 PM ETAMD$508.30+17.47(+3.75%)GLOBAL MARKETS-US stock futures dip as investors await midterm election results8:03:01 PM ETAAPL$329.82-6.69(-1.98%)Apple Readies Launch of AI-Powered Health App7:42:21 PM ETAMGN$456.00-4.12(-0.89%)Amgen (AMGN) Reports Q3 Earnings: What Key Metrics Have to Say7:30:56 PM ETAAPL$329.82-6.69(-1.98%)Apple: 3 Key Takeaways for Long-Term Investors7:28:50 PM ETAMD$508.30+17.47(+3.75%)Here's why AMD's stock is rising — and sending a confident message about the AI trade7:17:00 PM ETAMD$508.30+17.47(+3.75%)AMD: Expensive For A Reason7:15:26 PM ETGOOG$276.96-1.04(-0.37%)Google responds to political backlash over removing search from schools that ban AI7:10:07 PM ETPLTR$172.60-2.96(-1.66%)Jim Cramer Says the Executioner Is “Axing Palantir and Apple.” What Investors Should Make of It7:09:17 PM ETABBV$285.06-2.88(-1.00%)AbbVie expands Oxford R&D facility as part of £120 million-plus investment7:08:52 PM ETTSLA$391.23-12.63(-3.13%)Tesla misled South Korean customers about automated-driving tech, consumer group alleges7:03:18 PM ETABBV$285.06-2.88(-1.00%)AbbVie expands Oxford R&D facility as part of £120 million-plus investment7:01:03 PM ETAMD$508.30+17.47(+3.75%)Advanced Micro (AMD) Reports Q3 Earnings: What Key Metrics Have to Say7:01:02 PM ETAMD$508.30+17.47(+3.75%)UPDATE 7-AMD forecast eases AI spending fears as data-center sales surge7:00:54 PM ETAMD$508.30+17.47(+3.75%)AMD: The Odds Are Getting Better, But The Bet Still Isn't Worth It (Upgrade)7:00:06 PM ET

TECH · NASDAQ

Bio-Techne Corporation

$72.52 +0.01 (+0.01%)

Company overview

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments: Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in life science research, diagnostics, and cell and gene therapy applications, including cytokines, growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflows.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$11.4B
Employees
3,100
Headquarters
Minneapolis, MN
Website
bio-techne.com
CEO
Kim Kelderman
Listed
February 9, 1989
P/E
102.14
Dividend yield
0.44%

Company financials

Revenue
$1.2B
Gross profit
$786M
Operating income
$154M
EBITDA
$259M
Net income
$110M
EPS
$0.71
Total assets
$2.6B
Total debt
$290M
Gross margin
64.96%
Net margin
9.05%
Earnings yield
0.98%

Revenue segmentation

By product (FY 2026)
By region (FY 2026)

Showing FY 2026

Price chart

42.0149.9957.9765.9573.93
TECH 1D NASDAQ O72.72H72.72L72.63C72.670.00 (0.00%)Vol2.59M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
TECHBio-Techne Corporation Press release BIO-TECHNE DECLARES DIVIDEND PR Newswire
TECHBio-Techne Corporation Stock news Bio-Techne's Q1 Earnings on Deck: What's in Store for the Stock? Zacks Investment Research
TECHBio-Techne Corporation Press release Press release: CMB.TECH fleet update GlobeNewswire
TECHBio-Techne Corporation Stock news CMB.TECH SPECIAL GENERAL MEETING RESULTS GlobeNewswire
TECHBio-Techne Corporation Press release Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development PRNewsWire
TECHBio-Techne Corporation Stock news INCY or TECH: Which Is the Better Value Stock Right Now? Zacks Investment Research
TECHBio-Techne Corporation Press release INTURAI PROVIDES DEFENCE TECH COMPETITION RESULTS AND COMPANY UPDATE PRNewsWire
TECHBio-Techne Corporation Press release Zhibao Technology Signs Definitive Agreement to Acquire NEXSYS TECH for Planned AI Computing Infrastructure Business Newsfile
TECHBio-Techne Corporation Press release Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany PR Newswire
TECHBio-Techne Corporation Press release Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration PRNewsWire
TECHBio-Techne Corporation Stock news Why Is Techne (TECH) Down 0.1% Since Last Earnings Report? Zacks Investment Research
TECHBio-Techne Corporation Legal Halper Sadeh LLC is Investigating Whether CSR, EFSI, FULC, GlobeNewswire
TECHBio-Techne Corporation Stock news CMB.TECH: Updates From Our Top Shipping Pick Of 2026 Seeking Alpha
TECHBio-Techne Corporation Legal BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Bio-Techne Corporation (Nasdaq – TECH) GlobeNewswire
TECHBio-Techne Corporation Legal Halper Sadeh LLC is Investigating Whether TECH, CBAN, AUUD are Obtaining Fair Deals for their Shareholders GlobeNewswire
TECHBio-Techne Corporation Press release PRESS RELEASE: CMB.TECH announces special general meeting on 8 October 2026 GlobeNewswire
TECHBio-Techne Corporation Press release Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals PRNewsWire
TECHBio-Techne Corporation Stock news CMB.TECH: Q2 Was Strong, But Valuation Looks Full (Downgrade) Seeking Alpha
TECHBio-Techne Corporation Stock news CMB.TECH NV (CMBT) Q2 2026 Earnings Call Transcript Seeking Alpha
TECHBio-Techne Corporation Stock news CMB.TECH Q2 Earnings Call Highlights MarketBeat
See more
FAQ

Questions about Bio-Techne Corporation

What does Bio-Techne Corporation do?
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments: Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in life science research, diagnostics, and cell and gene therapy applications, including cytokines, growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflows.
What is TECH's market cap?
Bio-Techne Corporation (TECH) is a listed stock with a live quote. The latest market cap on this page is $11.4B.
Where is Bio-Techne Corporation headquartered?
Bio-Techne Corporation is headquartered in Minneapolis, MN.
How do I get TECH news from the API?
Call GET /v1/news?tickers=TECH. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does TECH news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for TECH, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the TECH price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs